Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Debate: First-Line Immunotherapy of MSI-H Colorectal Cancer: Single Agent vs. Combination Therapy. - Combination Therapy.
Thursday, September 23, 2021
2:38 PM – 2:46 PM
CDT
Debate Speaker(s)
Kristen K. Ciombor, MD, MSCI
Vanderbilt-Ingram Cancer Center
This talk is supported by educational grants provided by Bayer HealthCare Pharmaceuticals, Inc., Pfizer
Inc. and Taiho Oncology, Inc.
